Unicycive Therapeutics UNCY
NASDAQ UNCY
$3.87 +0.07 (+1.84%)
At close: Oct 21, 2026 · 4:00 PM EDT

Unicycive Therapeutics (UNCY) Debt Ratio (2020 - 2024)

Updated

Unicycive Therapeutics' (UNCY) Debt Ratio came in at 0.00 for Q1 2024.

Analysis

Unicycive Therapeutics (UNCY) Debt Ratio (2020 - 2024) Analysis & Trends

For FY2020, Unicycive Therapeutics' Debt Ratio stood at 12.23.

  • The Q1 2024 figure stands as the highest quarterly Debt Ratio since Q3 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 0.39
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 0.24
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 0.52
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 0.42
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 0.08
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 0.28
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 0.60
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 0.53
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 0.31
10 Unicycive Therapeutics 104.17 Mn -95.81 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2024 0.00
Sep 30, 2021 0.01
Jun 30, 2021 4.49
Dec 31, 2020 12.23
API Access

Unicycive Therapeutics Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=UNCY&period=max&api_key=YOUR_API_KEY